122 related articles for article (PubMed ID: 9685700)
1. A search for novel tumour suppressor genes for adult acute leukaemia by allelotyping at sub-telomeric chromosomal regions.
Giphart-Gassler M; De Nooij-Van Dalen A; Van Buuren-Van Seggelen V; Morolli B; Lohman P; Kluin-Nelemans H
Mutat Res; 1998 May; 400(1-2):409-19. PubMed ID: 9685700
[TBL] [Abstract][Full Text] [Related]
2. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
6. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
[TBL] [Abstract][Full Text] [Related]
7. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at 9p and 17q in human laryngeal tumors.
Kiaris H; Spanakis N; Ergazaki M; Sourvinos G; Spandidos DA
Cancer Lett; 1995 Oct; 97(1):129-34. PubMed ID: 7585472
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in neuroblastomas--an overview.
Takita J; Hayashi Y; Yokota J
Eur J Cancer; 1997 Oct; 33(12):1971-3. PubMed ID: 9516835
[TBL] [Abstract][Full Text] [Related]
10. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
14. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
Gomes CC; Fonseca-Silva T; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
[TBL] [Abstract][Full Text] [Related]
15. Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia.
Baccichet A; Sinnett D
Br J Haematol; 1997 Oct; 99(1):107-14. PubMed ID: 9359510
[TBL] [Abstract][Full Text] [Related]
16. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
17. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
18. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
[TBL] [Abstract][Full Text] [Related]
19. Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity.
de Nooij-van Dalen AG; van Buuren-van Seggelen VH; Mulder A; Gelsthorpe K; Cole J; Lohman PH; Giphart-Gassler M
Mutat Res; 1997 Mar; 374(1):51-62. PubMed ID: 9067415
[TBL] [Abstract][Full Text] [Related]
20. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
